Glycine inhibits melanogenesis in vitro and causes hypopigmentation in vivo.
The simplest amino acid, glycine, is important in protein composition and plays a significant role in numerous physiological events in mammals. Despite the inhibitory effect of glycine on spontaneous melanogenesis in B16F0 melanoma cells, the details of the underlying mechanisms remain unknown. The present study was conducted to investigate the further effects and the mechanisms of inhibitory effect of glycine on melanogenesis using B16F0 melanoma cells and hair follicle melanogenesis in C57BL/6J mice. Treatment with glycine (1-16 mM) for 72 h inhibited alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenesis in a concentration-dependent manner without any effects on cell proliferation in B16F0 melanoma cells. Treatment with kojic acid (2.5 mM) for 72 h also inhibited alpha-MSH-induced melanogenesis in B16F0 melanoma cells. The highest dose of glycine inhibited the alpha-MSH-induced increment of tyrosinase protein levels in B16F0 melanoma cells. In hair follicle melanogenesis in C57BL/6J mice, treatment with glycine (1250 or 2500 mg/kg, i.p.) for 5 d prevented the decrement of L* and C* values and inhibited the increment of tyrosinase protein levels and melanin content within the skin. Treatment with hydroquinone (100 mg/kg, i.p.) for 5 d had a similar hypopigmenting effect to that of high dose glycine. These results suggest that glycine has an inhibitory effect on melanogenesis that is mediated by down-regulation of tyrosinase protein levels, leading to a hypopigmenting effect in C57BL/6J mice.
Ishikawa
Masago
M
Drug Evaluation Department, Life Science Institute, SSP CO. LTD., 1143 Nanpeidai, Narita, Japan.
Kawase
Ichiro
I
Ishii
Fumio
F
D000596:Amino Acids / Q000494:pharmacology*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D045744:Cell Line, Tumor; D004305:Dose-Response Relationship, Drug; D005260:Female; D005998:Glycine / Q000494:pharmacology*; D018859:Hair Follicle / Q000187:drug effects; D006873:Hydroquinones / Q000494:pharmacology; D066298:In Vitro Techniques; D008543:Melanins / Q000032:analysis / Q000037:antagonists & inhibitors*; D008546:Melanoma, Experimental / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D014442:Monophenol Monooxygenase / Q000037:antagonists & inhibitors; D010858:Pigmentation / Q000187:drug effects*; D011753:Pyrones / Q000494:pharmacology; D013997:Time Factors; D000521:alpha-MSH / Q000494:pharmacology
D000596:Amino Acids; D000975:Antioxidants; D006873:Hydroquinones; D008543:Melanins; D011753:Pyrones; D000521:alpha-MSH; C011890:kojic acid; D014442:Monophenol Monooxygenase; D005998:Glycine; C031927:hydroquinone